Avoiding a nanotech backlash

United Kingdom report warns of GM-style problems unless a wider public debate is started

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

If companies developing nanotechnology products want to avoid being hit with the sort of backlash that crop firms have suffered over genetic modification (GM), there needs to be public debate at an earlier stage of research and development, a British think tank said on Wednesday, September 1.

In a new report from Demos, James Wilsdon and Rebecca Willis argue that companies haven't learned the lessons that GM should have taught them.

"Nanoparticles are already used in everyday products like sunscreens. But it's not clear that the lessons of GM have really hit home," they said in a statement. "The public wants to know that nanotechnologies are safe, but we also want to know who owns the technology, who will benefit from it, and how it will change our lives. Unless a meaningful debate starts soon, scientists could be facing another public backlash."

The report, produced in partnership with the Environment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Stephen Pincock

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours